Everchain VP, Brooke Teal's 10-week Leukemia & Lymphoma Society (LLS) Man & Woman of the Year (Atlanta) Fundraising Campaign has come to an end and we are THRILLED to share that she was named RUNNER UP for raising $163,585 to battle Leukemia!
.png?width=176&name=MicrosoftTeams-image%20(21).png)
.png?width=149&name=MicrosoftTeams-image%20(17).png)
Please join us in recognizing Brooke in this impactful and meaningful accomplishment, dedicated to the memory of her grandfather, Bill Teal, who was a leukemia patient and a veteran. The LLS mission is to cure blood cancer and improve the quality of life of patients and their families focusing on research, advocacy, and patient support. A cancer diagnosis is the leading cause of medical debt and Brooke is supporting consumers in these difficult circumstances.
Due to her fundraising efforts, Brooke was awarded the unique opportunity to link a mission portfolio to Patient Financial Support in EverChain’s name. The Atlanta Man and Woman of the Year campaign raised $2,432,808 in total.
Those donations will not only support LLS research, but patient services, advocacy, public and professional education, and community services as well. Over the years, support from people like Brooke has been responsible for the blood cancer advancements that have doubled, tripled, and in some cases quadrupled the survival rate for some blood cancers.
Many LLS supported therapies not only help blood cancer patients but are also now used to treat patients with rare forms of stomach and skin cancers and are in clinical trials for patients with lung, brain, breast, pancreatic and prostate cancers. And LLS funded drugs like targeted therapies and immunotherapies are now saving thousands of lives every day. We truly are getting close to our goal of a world without blood cancers! Brooke can be reached at bteal@everchain.com or on LinkedIn. For more information about LLS, please visit www.lls.org. You can view the footage of Brooke being announced as Runner Up for Woman of the Year in the video below.
